44.36000 EUR
0.16
0.36%
Last update Dec 18, 4:32 PM CET
Market closed
Day range
44.36000
44.5
Previous close
44.52000
Open
44.5
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
44.36
0.16
0.36%

Statistics

Valuation metrics
Market cap
8.76B
Enterprise value
6.56B
Trailing P/E (ttm)
19.43
Forward P/E
PEG ratio
Price/Sales (ttm)
2.84
Price/Book (mrq)
1.66
Enterprise Value/Revenue
2.49
Enterprise Value/EBITDA
9.69
Overview
Shares outstanding
192.10M
Float
190.47M
Shares short
% Held by insiders
0.77%
% Held by institutions
98.10%
Average volume (10 days)
46
Average volume (90 days)
27
Price summary
52-Week low
43.05
52-Week high
68.02
52-Week change
-43.33 -100.6%
Beta
0.30
50-Day moving average
45.82
200-Day moving average
50.43
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
16.82%
Operating margin
-6.02%
Operational effectiveness
Return on assets
6.15%
Return on equity
9.07%
Income statement
Revenue (ttm)
2.64B
Revenue per share (ttm)
16.17
Quarterly revenue growth (yoy)
4.10%
Gross profit (ttm)
2.14B
EBITDA
546.04M
Net income to common (ttm)
443.65M
Diluted EPS (ttm)
2.29
Quarterly earnings growth (yoy)
2.38%
Balance sheet
Total cash (mrq)
1.26B
Total cash per share (mrq)
7.69
Total debt (mrq)
515.11M
Total Debt/Equity (mrq)
9.98
Current ratio (mrq)
482.80%
Book value per share (mrq)
26.84
Cash flow
Cash flow statement
779.16M
Levered free cash flow (LFCF)
384.94M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 13 hours 3 minutes

18:56
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).